These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14977815)

  • 1. Targeting cancer with telomerase: commentary re Q. Huang et al., a novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells. Clin. Cancer Res., 10: 1439-1445, 2004.
    Hahn WC
    Clin Cancer Res; 2004 Feb; 10(4):1203-5. PubMed ID: 14977815
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells.
    Huang Q; Zhang X; Wang H; Yan B; Kirkpatrick J; Dewhrist MW; Li CY
    Clin Cancer Res; 2004 Feb; 10(4):1439-45. PubMed ID: 14977847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of telomerase activity and telomere length to chemosensitivity.
    Kiyozuka Y
    Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the telosome: therapeutic implications.
    Folini M; Gandellini P; Zaffaroni N
    Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere and telomerase as targets for cancer therapy.
    Tian X; Chen B; Liu X
    Appl Biochem Biotechnol; 2010 Mar; 160(5):1460-72. PubMed ID: 19412578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
    Crees Z; Girard J; Rios Z; Botting GM; Harrington K; Shearrow C; Wojdyla L; Stone AL; Uppada SB; Devito JT; Puri N
    Curr Pharm Des; 2014; 20(41):6422-37. PubMed ID: 24975605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting telomere maintenance mechanisms in cancer therapy.
    Folini M
    Curr Pharm Des; 2014; 20(41):6359-60. PubMed ID: 24975602
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospects for anti-neoplastic therapies based on telomere biology.
    Stewart SA; Hahn WC
    Curr Cancer Drug Targets; 2002 Mar; 2(1):1-17. PubMed ID: 12188917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer therapy targeting telomeres and telomerase : current status.
    Parkinson EK; Minty F
    BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomeres and telomerase: understanding basic structure and potential new therapeutic strategies targeting it in the treatment of cancer.
    Sekhri K
    J Postgrad Med; 2014; 60(3):303-8. PubMed ID: 25121374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibition as cancer therapy.
    Saretzki G
    Cancer Lett; 2003 May; 194(2):209-19. PubMed ID: 12757979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.
    Kim JH; Lee GE; Kim JC; Lee JH; Chung IK
    Mol Cells; 2002 Apr; 13(2):228-36. PubMed ID: 12018844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
    Kelland L
    Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase-based therapies emerging slowly.
    Brower V
    J Natl Cancer Inst; 2010 Apr; 102(8):520-1. PubMed ID: 20388877
    [No Abstract]   [Full Text] [Related]  

  • 20. Telomeres and telomerase: Biological and clinical importance in dogs.
    Nasir L
    Vet J; 2008 Feb; 175(2):155-63. PubMed ID: 17398127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.